Kedan A - Search Results

1

The phosphatidylinositol-transfer protein Nir2 binds phosphatidic acid and positively regulates phosphoinositide signalling.

Kim S, Kedan A, Marom M, Gavert N, Keinan O, Selitrennik M, Laufman O, Lev S. Kim S, et al. Among authors: kedan a. EMBO Rep. 2013 Oct;14(10):891-9. doi: 10.1038/embor.2013.113. Epub 2013 Jul 30. EMBO Rep. 2013. PMID: 23897088 Free PMC article.

2

Direct interaction between the COG complex and the SM protein, Sly1, is required for Golgi SNARE pairing.

Laufman O, Kedan A, Hong W, Lev S. Laufman O, et al. Among authors: kedan a. EMBO J. 2009 Jul 22;28(14):2006-17. doi: 10.1038/emboj.2009.168. Epub 2009 Jun 18. EMBO J. 2009. PMID: 19536132 Free PMC article.

3

The lipid-transfer protein Nir2 enhances epithelial-mesenchymal transition and facilitates breast cancer metastasis.

Keinan O, Kedan A, Gavert N, Selitrennik M, Kim S, Karn T, Becker S, Lev S. Keinan O, et al. Among authors: kedan a. J Cell Sci. 2014 Nov 1;127(Pt 21):4740-9. doi: 10.1242/jcs.155721. Epub 2014 Sep 1. J Cell Sci. 2014. PMID: 25179602

4

Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 Axis.

Verma N, Müller AK, Kothari C, Panayotopoulou E, Kedan A, Selitrennik M, Mills GB, Nguyen LK, Shin S, Karn T, Holtrich U, Lev S. Verma N, et al. Among authors: kedan a. Cancer Res. 2017 Jan 1;77(1):86-99. doi: 10.1158/0008-5472.CAN-16-1797. Epub 2016 Oct 28. Cancer Res. 2017. PMID: 27793840

5

PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein.

Kedan A, Verma N, Saroha A, Shreberk-Shaked M, Müller AK, Nair NU, Lev S. Kedan A, et al. Cell Death Dis. 2018 Sep 24;9(10):985. doi: 10.1038/s41419-018-1005-z. Cell Death Dis. 2018. PMID: 30250159 Free PMC article.

6

Correction: The lipid-transfer protein Nir2 enhances epithelial-mesenchymal transition and facilitates breast cancer metastasis (doi:10.1242/jcs.155721).

Keinan O, Kedan A, Gavert N, Selitrennik M, Kim S, Karn T, Becker S, Lev S. Keinan O, et al. Among authors: kedan a. J Cell Sci. 2019 Mar 7;132(5):jcs227868. doi: 10.1242/jcs.227868. J Cell Sci. 2019. PMID: 30846603 No abstract available.

7

Correction: Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 Axis.

Verma N, Müller AK, Kothari C, Panayotopoulou E, Kedan A, Selitrennik M, Mills GB, Nguyen LK, Shin S, Karn T, Holtrich U, Lev S. Verma N, et al. Among authors: kedan a. Cancer Res. 2020 Jan 15;80(2):362. doi: 10.1158/0008-5472.CAN-19-3573. Cancer Res. 2020. PMID: 31941679 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters